))
Integra LifeSciences to buy J&J's Acclarent; Ashley McEvoy takes board role at consumer goods giant
Fetch error
Hmmm there seems to be a problem fetching this series right now.
Last successful fetch was on March 15, 2024 10:03 (
What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 389402849 series 3481361
Contenu fourni par Fast Five by MassDevice. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par Fast Five by MassDevice ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.
Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, December 14, 2023. Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast. Ekso Bionics announced it earned a Medicare win for its exoskeleton technology this week. Fast Five hosts Sean Whooley and Danielle Kirsh discuss what the win means for the company and the technology it is developing. Calyxo closed a $50 million funding round to support kidney stone treatment. Hear how much funding the company has received in recent years and what the company's technology does. Tandem Diabetes Care has launched its diabetes management platform for insulin pump users. Whooley talks about what the new platform is designed for and some other positive news from the company in recent months. Former Johnson & Johnson MedTech head Ashley McEvoy has landed a board position at a consumer goods giant. Learn where she is joining the board in today's episode. Integra LifeSciences is buying J&J's Acclarent and its ENT technology. Whooley and Kirsh discuss the financial details of the deal and how it will supplement Integra LifeSciences' portfolio.
…
continue reading
161 episodes
Partager
